Wnt signaling and cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alman, 1997, Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)., Am. J. Pathol., 151, 329
Bradbury, 1994, Alterations of the growth characteristics of the fibroblast cell line C3H 10T1/2 by members of the Wnt gene family., Oncogene, 9, 2597
Brannon, 1999, XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development., Development, 126, 3159, 10.1242/dev.126.14.3159
Dennis, 1999, A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling., J. Cell. Sci., 112, 3815, 10.1242/jcs.112.21.3815
Dihlmann, 1999, Dominant negative effect of the APC1309 mutation: A possible explanation for genotype-phenotype correlations in familial adenomatous polyposis., Cancer Res., 59, 1857
Duval, 1999, Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability., Cancer Res., 59, 4213
Fukuchi, 1998, Beta-catenin mutation in carcinoma of the uterine endometrium., Cancer Res., 58, 3526
Garcia-Rostan, 1999, Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma., Cancer Res., 59, 1811
Greaves, 1999, A screen for identifying genes interacting with armadillo, the Drosophila homolog of beta-catenin., Genetics, 153, 1753, 10.1093/genetics/153.4.1753
Hedgepeth, 1999, Regulation of glycogen synthase kinase 3β and downstream Wnt signaling by axin., Mol. Cell Biol., 19, 7147, 10.1128/MCB.19.10.7147
Huang, 1999, Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection., Am. J. Pathol., 155, 1795, 10.1016/S0002-9440(10)65496-X
Iwao, 1998, Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations., Cancer Res., 58, 1021
Kartheuser, 1999, Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3′ APC mutation., J. Med. Genet., 36, 65
Kishida, 1999, DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability., Mol. Cell. Biol., 19, 4414, 10.1128/MCB.19.6.4414
Kitaeva, 1997, Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors., Cancer Res., 57, 4478
Koch, 1999, Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene., Cancer Res., 59, 269
Koesters, 1999, Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors., Cancer Res., 59, 3880
Lasser, 1994, Turcot's syndrome: Evidence for linkage to the adenomatous polyposis coli (APC) locus., Neurology, 44, 1083, 10.1212/WNL.44.6.1083
Lee, 2000, SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm., Development, 127, 109, 10.1242/dev.127.1.109
Mirabelli-Primdahl, 1999, Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway., Cancer Res., 59, 3346
Miyaki, 1999, Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer., Cancer Res., 59, 4506
Miyoshi, 1998, Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3., Cancer Res., 58, 2524
Nagase, 1992, Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients., Cancer Res., 52, 4055
Nishida, 1994, Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma., Cancer Res., 54, 3107
Oshima, 1995, Evidence against dominant negative mechanisms of intestinal polyp formation by APC gene mutations., Cancer Res., 55, 2719
Palacios, 1998, Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas., Cancer Res., 58, 1344
Park, 1999, Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer., Cancer Res., 59, 4257
Peng, 1993, Amplification of the c-myc gene in human hepatocellular carcinoma: Biologic significance., J. Formos Med. Assoc., 92, 866
Prieve, 1999, Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression., Mol. Cell. Biol., 19, 4503, 10.1128/MCB.19.6.4503
Roose, 1999, TCF transcription factors: Molecular switches in carcinogenesis., Biochim. Biophys. Acta., 1424, M23
Samowitz, 1999, Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas., Cancer Res., 59, 1442
Shih, 2000, The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression., Cancer Res., 60, 1671
Shimizu, 1997, Transformation by Wnt family proteins correlates with regulation of beta-catenin., Cell Growth Differ., 8, 1349
Song, D.H., Sussman, D.J., and Seldin, D.C. 2000. Endogenous protein kinase CK2 (casein kinase II) participates in Wnt signaling in mammary epithelial cells. J. Biol. Chem. (in press)..
Sparks, 1998, Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer., Cancer Res., 58, 1130
Umeda, 2000, beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice., Int. J. Oncol., 16, 1133
Van Nhieu, 1999, Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation., Am. J. Pathol., 155, 703, 10.1016/S0002-9440(10)65168-1
Voeller, 1998, Beta-catenin mutations in human prostate cancer., Cancer Res., 58, 2520
Willert, 1999, A Drosophila Axin homolog, Daxin, inhibits Wnt signaling., Development, 126, 4165, 10.1242/dev.126.18.4165
Xu, 2000, WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene., Genes & Dev., 14, 585, 10.1101/gad.14.5.585
Zurawel, 1998, Sporadic medulloblastomas contain oncogenic beta-catenin mutations., Cancer Res., 58, 896